North America In-Vitro Diagnostics Market is predicted to reach USD 43.64 Billion by 2030

According to the study by Next Move Strategy Consulting, the North America In-Vitro Diagnostics Market size is predicted to reach USD 43.64 billion, at a CAGR of 3.4% by 2030.

Request  a FREE Sample: https://www.nextmsc.com/north-america-in-vitro-diagnostics-market/request-sample

The increasing prevalence of chronic and infectious diseases such as cancer, cardiovascular conditions, diabetes, and various infections is driving the demand for diagnostic tests in the global in-vitro diagnostics market.

The aging population, marked by a rising prevalence of age-related diseases and conditions worldwide, is a key driver for the growth of the market in the region.

The prevalence of chronic diseases serves as a significant growth driver for the IVD market in the U.S. 

The promising players operating in the North America in-vitro diagnostics market include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.